Notch signaling pathway in tumor immune microenvironment

Roles of Notch signaling pathway in tumor immune microenvironment. Notch signaling can affect the activity of various immune cells within tumor microenvironment. Notch signaling suppresses PMN-MDSC production and induces MDSC expansion, contributing to tumor immunosuppression. Intriguingly, PMN-MDSCs can elicit Jag/Notch signal transduction pathway in cancer cell. The crosstalk between cancer cells and PMN-MDSCs finally enhances cancer metastasis. Notch signaling play dual roles in regulating T cell-mediated immune responses in cancer. Notch pathway can affect TAM recruitment and polarization. Cancer cells trigger the activation of Notch signaling in endothelial cells, which mediates the education of TAMs by cancer cells. This leads to formation of immunosuppressive microenvironment and impairment of T cell-mediated immunity. Notch activation reduces the intratumoral infiltration of NK cells, while it has opposite effects on Treg frequency and activity. Notch signaling leads to IL-17-driven inflammation via Th17 recruitment. Notch signaling mediates the communication between cancer cells and CAFs. On one hand, activated Notch pathway in CAFs causes compromised antitumor immunity and supports cancer development. On the other hand, increased activity of Notch pathway in CAFs can inhibit cancer progression. Cancer cells attract neutrophils into tumor microenvironment and motivate Notch signaling in recruited neutrophils. Notch-activated neutrophils suppress the cytotoxic activity of CD8+ T cells. Notch signaling fosters DC terminal differentiation and drives antigen cross-presentation to CD8+ T cells. Consequently, Notch-primed DCs retard cancer progression. Notch mutation is associated with a decline in B cell population in tumor microenvironment. Furthermore, Notch activation upregulates immune checkpoints (PD-1 and PD-L1) to blunt adaptive antitumor immunity. MDSC, myeloid-derived suppressor cell; Dlls, Delta-like ligands; PMN-MDSC, polymorphonuclear-myeloid-derived suppressor cell; PD-1, programmed cell death protein-1; PD-L1, programmed cell death protein-ligand 1; DC, dendritic cell; Jags, Jaggeds; CAF, cancer-associated fibroblast; Th17, T helper 17; Treg cell, regulatory T cell; NK cell, natural killer cell; TAMs, tumor-associated macrophages
Notch signaling pathway in tumor immune microenvironment

Publication

Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy (2024) Man Wang, et al. Front Immunol. 2024;15(NA). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TAM TAM ncbigene_symbol TAM 8205
Homo sapiens Primates TAM TAM ncbigene_synonym STIM1 6786
Homo sapiens Primates Notch NOTCH famplex_relations NOTCH1 4851
Homo sapiens Primates Notch NOTCH famplex_relations NOTCH2 4853
Homo sapiens Primates Notch NOTCH famplex_relations NOTCH3 4854
Homo sapiens Primates Notch NOTCH famplex_relations NOTCH4 4855
Homo sapiens Primates CD4+ CD4 ncbigene_symbol CD4 920
Homo sapiens Primates CD8 CD8 ncbigene_synonym CD8A 925
Homo sapiens Primates CD8 CD8 famplex_relations CD8B 926
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym PDCD1 5133
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym RPL17 6139
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym RPL17-C18orf32 100526842
Homo sapiens Primates PD-L1 PD-L1 ncbigene_synonym CD274 29126
Homo sapiens Primates bils BII ncbigene_synonym CACNA1E 777
Homo sapiens Primates CAF CAF ncbigene_synonym KAT2B 8850
Homo sapiens Primates h17 H17 ncbigene_symbol H1-7 341567
Homo sapiens Primates h17 H17 ncbigene_synonym FOXRED1 55572

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID
Cancer cancer cancer DOID:162